Phenotypic variation in familial melanoma: consequences for predictive DNA testing.
Bergman
Wilma
W
Gruis
Nelleke A
NA
D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D020022:Genetic Predisposition to Disease; D018095:Germ-Line Mutation; D005858:Germany; D006689:Hodgkin Disease / Q000235:genetics; D006801:Humans; D008545:Melanoma / Q000235:genetics*; D009378:Neoplasms, Multiple Primary / Q000235:genetics*; D009426:Netherlands; D010051:Ovarian Neoplasms / Q000235:genetics; D010641:Phenotype; D044102:Receptor, Melanocortin, Type 1 / Q000235:genetics; D012878:Skin Neoplasms / Q000235:genetics*
D019941:Cyclin-Dependent Kinase Inhibitor p16; D044102:Receptor, Melanocortin, Type 1